a diabetes - myconference suite › images › docs › a_diabetes... · emerging diabetes trial...
TRANSCRIPT
EMERGING DIABETES TRIAL RESULTS AND HOW THEY WILL SHAPE OUR MANAGEMENT STRATEGIES
A Diabetes Breakthrough
L I KA SHING KNOWLEDGE INST ITUTE 209 V ICTORIA STREET, TORONTO M5B 1T8
SATURDAY DECEMBER 8
2018
FACULTYLawrence A. Leiter, MD, FRCPC, FACP, FACE,FAHA, FACCChairEndocrinologist, St. Michael’s HospitalProfessor of Medicine and Nutritional Sciences, University of Toronto,Toronto, ON
Subodh Verma, MD, PhD, FRCSC, FAHACo-Chair Cardiac Surgeon, St. Michael’s HospitalProfessor of Surgery and Pharmacology & Toxicology, University of Toronto, Canada Research Chair in Cardiovascular Surgery Toronto, ON
Peter J. Lin, MD, CCFPDirector, Primary Care Initiatives, Canadian Heart Research CentreMedical Director, LinCorp Medical Inc.Toronto, ON
Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist,North York General Hospital & LMC Diabetes & EndocrinologyVaughan, ON
7:45 am Breakfast and Registration
8:30 am Opening Remarks Dr. Lawrence A. Leiter
8:40 am Diabetes, CV Disease and the Rationale for the DECLARE-TIMI 58 Trial
Dr. Subodh Verma
9:05 am Results from the DECLARE-TIMI 58 Trial
Dr. Stephen D. Wiviott
9:35 am Results from a Meta-Analysis of the SGLT2i CVOTs
Dr. Marc S. Sabatine
10:05 am Nutrition Break
10:35 am Clinical Implications of the DECLARE-TIMI 58 Trial Results
Dr. Lawrence A. Leiter
10:55 am Q&A and Panel Discussion
11:45 am Translating the Evidence into Practice (Case-based presentations with key learnings for primary care practitioners and specialists)
Drs. Subodh Verma, Ronald M. Goldenberg and Peter J. Lin
12:30 pm Closing Remarks Dr. Subodh Verma
AGENDA
Stephen D. Wiviott, MD, FACCCardiologist, Brigham and Women’s HospitalAssociate Professor of Medicine, Harvard Medical SchoolBoston, MA
Marc S. Sabatine,MD, MPH, FACCChairman, TIMI Study GroupLewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine,Brigham and Women’s HospitalProfessor of Medicine,Harvard Medical SchoolBoston, MA
This program has received an educational grant from: AstraZeneca
To register: www.ADiabetesBreakthrough.com
• To review the relationship between diabetes and cardiovascular disease.• To summarise the findings from cardiovascular outcome trials in diabetes that have reported.• To discuss how to implement the clinical trial evidence into everyday practice to optimize diabetes management.
LEARNING OBJECTIVES
This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 3.50 Mainpro+ credits.